These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

550 related items for PubMed ID: 23199378

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Anterior lumbar interbody fusion using recombinant human bone morphogenetic protein-2: a prospective study of complications.
    Malham GM, Parker RM, Ellis NJ, Blecher CM, Chow FY, Claydon MH.
    J Neurosurg Spine; 2014 Dec; 21(6):851-60. PubMed ID: 25279655
    [Abstract] [Full Text] [Related]

  • 3. Retrograde ejaculation after anterior lumbar interbody fusion with and without bone morphogenetic protein-2 augmentation: a 10-year cohort controlled study.
    Comer GC, Smith MW, Hurwitz EL, Mitsunaga KA, Kessler R, Carragee EJ.
    Spine J; 2012 Oct; 12(10):881-90. PubMed ID: 23098617
    [Abstract] [Full Text] [Related]

  • 4. Posterior lumbar interbody fusion using recombinant human bone morphogenetic protein type 2 with cylindrical interbody cages.
    Haid RW, Branch CL, Alexander JT, Burkus JK.
    Spine J; 2004 Oct; 4(5):527-38; discussion 538-9. PubMed ID: 15363423
    [Abstract] [Full Text] [Related]

  • 5. Retrograde ejaculation after anterior lumbar interbody fusion using rhBMP-2: a cohort controlled study.
    Carragee EJ, Mitsunaga KA, Hurwitz EL, Scuderi GJ.
    Spine J; 2011 Jun; 11(6):511-6. PubMed ID: 21612985
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Quantitative assessment of retrograde ejaculation using semen analysis, comparison with a standardized qualitative questionnaire, and investigating the impact of rhBMP-2.
    Tepper G, Rabbani R, Yousefzadeh M, Prince D.
    Spine (Phila Pa 1976); 2013 May 01; 38(10):841-5. PubMed ID: 23403551
    [Abstract] [Full Text] [Related]

  • 8. Transforaminal lumbar interbody fusion with rhBMP-2 in spinal deformity, spondylolisthesis, and degenerative disease--part 1: Large series diagnosis related outcomes and complications with 2- to 9-year follow-up.
    Crandall DG, Revella J, Patterson J, Huish E, Chang M, McLemore R.
    Spine (Phila Pa 1976); 2013 Jun 01; 38(13):1128-36. PubMed ID: 23370679
    [Abstract] [Full Text] [Related]

  • 9. Heterotopic ossification following single-level anterior cervical discectomy and fusion: results from the prospective, multicenter, historically controlled trial comparing allograft to an optimized dose of rhBMP-2.
    Arnold PM, Anderson KK, Selim A, Dryer RF, Kenneth Burkus J.
    J Neurosurg Spine; 2016 Sep 01; 25(3):292-302. PubMed ID: 27129045
    [Abstract] [Full Text] [Related]

  • 10. Six-year outcomes of anterior lumbar interbody arthrodesis with use of interbody fusion cages and recombinant human bone morphogenetic protein-2.
    Burkus JK, Gornet MF, Schuler TC, Kleeman TJ, Zdeblick TA.
    J Bone Joint Surg Am; 2009 May 01; 91(5):1181-9. PubMed ID: 19411467
    [Abstract] [Full Text] [Related]

  • 11. Blood serum antibody analysis and long-term follow-up of patients treated with recombinant human bone morphogenetic protein-2 in the lumbar spine.
    Burkus JK, Gornet MF, Glassman SD, Slosar PJ, Rosner MK, Deckey JE, Nowak J, Hatcher BM.
    Spine (Phila Pa 1976); 2011 Dec 01; 36(25):2158-67. PubMed ID: 21325990
    [Abstract] [Full Text] [Related]

  • 12. Transforaminal lumbar interbody fusion with rhBMP-2 in spinal deformity, spondylolisthesis, and degenerative disease--part 2: BMP dosage-related complications and long-term outcomes in 509 patients.
    Crandall DG, Revella J, Patterson J, Huish E, Chang M, McLemore R.
    Spine (Phila Pa 1976); 2013 Jun 01; 38(13):1137-45. PubMed ID: 23354111
    [Abstract] [Full Text] [Related]

  • 13. A prospective, randomized, controlled trial comparing radiographic and clinical outcomes between stand-alone lateral interbody lumbar fusion with either silicate calcium phosphate or rh-BMP2.
    Pimenta L, Marchi L, Oliveira L, Coutinho E, Amaral R.
    J Neurol Surg A Cent Eur Neurosurg; 2013 Nov 01; 74(6):343-50. PubMed ID: 23444134
    [Abstract] [Full Text] [Related]

  • 14. Symptomatic ectopic bone formation after off-label use of recombinant human bone morphogenetic protein-2 in transforaminal lumbar interbody fusion.
    Chen NF, Smith ZA, Stiner E, Armin S, Sheikh H, Khoo LT.
    J Neurosurg Spine; 2010 Jan 01; 12(1):40-6. PubMed ID: 20043763
    [Abstract] [Full Text] [Related]

  • 15. Prospective, randomized, multicenter Food and Drug Administration investigational device exemption study of lumbar total disc replacement with the CHARITE artificial disc versus lumbar fusion: five-year follow-up.
    Guyer RD, McAfee PC, Banco RJ, Bitan FD, Cappuccino A, Geisler FH, Hochschuler SH, Holt RT, Jenis LG, Majd ME, Regan JJ, Tromanhauser SG, Wong DC, Blumenthal SL.
    Spine J; 2009 May 01; 9(5):374-86. PubMed ID: 18805066
    [Abstract] [Full Text] [Related]

  • 16. Urological complications following use of recombinant human bone morphogenetic protein-2 in anterior lumbar interbody fusion: presented at the 2012 Joint Spine Section Meeting: clinical article.
    Lubelski D, Abdullah KG, Nowacki AS, Alvin MD, Steinmetz MP, Chakka S, Li Y, Gajewski N, Benzel EC, Mroz TE.
    J Neurosurg Spine; 2013 Feb 01; 18(2):126-31. PubMed ID: 23231356
    [Abstract] [Full Text] [Related]

  • 17. The effect of recombinant human bone morphogenetic protein-2 in single-level posterior lumbar interbody arthrodesis.
    Michielsen J, Sys J, Rigaux A, Bertrand C.
    J Bone Joint Surg Am; 2013 May 15; 95(10):873-80. PubMed ID: 23677353
    [Abstract] [Full Text] [Related]

  • 18. Lumbar disc arthroplasty with Maverick disc versus stand-alone interbody fusion: a prospective, randomized, controlled, multicenter investigational device exemption trial.
    Gornet MF, Burkus JK, Dryer RF, Peloza JH.
    Spine (Phila Pa 1976); 2011 Dec 01; 36(25):E1600-11. PubMed ID: 21415812
    [Abstract] [Full Text] [Related]

  • 19. Nerve injury and recovery after lateral lumbar interbody fusion with and without bone morphogenetic protein-2 augmentation: a cohort-controlled study.
    Lykissas MG, Aichmair A, Sama AA, Hughes AP, Lebl DR, Cammisa FP, Girardi FP.
    Spine J; 2014 Feb 01; 14(2):217-24. PubMed ID: 24269858
    [Abstract] [Full Text] [Related]

  • 20. Radiographic assessment of interbody fusion using recombinant human bone morphogenetic protein type 2.
    Burkus JK, Dorchak JD, Sanders DL.
    Spine (Phila Pa 1976); 2003 Feb 15; 28(4):372-7. PubMed ID: 12590213
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 28.